| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase.
|
J Clin Invest
|
2007
|
4.44
|
|
2
|
Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.
|
J Clin Invest
|
2004
|
4.27
|
|
3
|
Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase.
|
Science
|
2002
|
4.02
|
|
4
|
Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes.
|
Blood
|
2009
|
2.88
|
|
5
|
Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion.
|
J Immunol
|
2003
|
2.54
|
|
6
|
Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific.
|
J Reprod Immunol
|
2004
|
2.30
|
|
7
|
Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses.
|
J Immunol
|
2002
|
2.14
|
|
8
|
Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase.
|
Int Immunol
|
2004
|
2.13
|
|
9
|
Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division.
|
Immunology
|
2002
|
1.57
|
|
10
|
Tolerance to apoptotic cells is regulated by indoleamine 2,3-dioxygenase.
|
Proc Natl Acad Sci U S A
|
2012
|
1.37
|
|
11
|
Tryptophan catabolism and T cell responses.
|
Adv Exp Med Biol
|
2003
|
1.34
|
|
12
|
Blockade of programmed death-1 pathway rescues the effector function of tumor-infiltrating T cells and enhances the antitumor efficacy of lentivector immunization.
|
J Immunol
|
2010
|
1.15
|
|
13
|
Marginal zone CD169+ macrophages coordinate apoptotic cell-driven cellular recruitment and tolerance.
|
Proc Natl Acad Sci U S A
|
2014
|
1.02
|
|
14
|
IFN-γ upregulates survivin and Ifi202 expression to induce survival and proliferation of tumor-specific T cells.
|
PLoS One
|
2010
|
0.96
|
|
15
|
A novel ERK-dependent signaling process that regulates interleukin-2 expression in a late phase of T cell activation.
|
J Biol Chem
|
2003
|
0.95
|
|
16
|
HY peptides modulate transplantation responses to skin allografts.
|
Int Immunol
|
2002
|
0.89
|
|
17
|
Indoleamine 2,3-dioxygenase, immunosuppression and pregnancy.
|
J Reprod Immunol
|
2002
|
0.86
|
|
18
|
The energy demands of portable gas analysis system carriage during walking and running.
|
Ergonomics
|
2013
|
0.75
|